In this video, Motley Fool health care analyst David Williamson gives us the story behind two big biotech jumps today and two big stumbles. Sequenom (NASDAQ: SQNM) continues its rally from Friday with more good news that its RetnaGene AMD accurately predicts the progression of wet age-related macular degeneration; this has shares up an additional 8% on top of Friday's 19%. Repros Therapeutics (NASDAQ: RPRX) also up today ahead of presenting both of its phase 2 drugs, Androxal and Proellex, at the Lazard conference tomorrow. Meanwhile, Cyclacel (NASDAQ: CYCC) and Transcept (NASDAQ: TSPT) are both down today after disappointing earnings releases.
A closer look at today's big market movers
About the Author
The Motley Fool's Healthcare Analyst, I specialize in Pharma, Biotech, and how the ACA (Obamacare) is changing the business of healthcare in America. Follow me on Twitter for breaking stock news, policy thoughts, and misc musings...
Follow @motleydavid